Search
Q32 Bio Inc
QTTBAdd to Watchlist
9.220USD
-0.340-3.56%
Close 09-24 16:00（ET）
274.39MMarket Cap
3.30P/E TTM
Q32 Bio Inc (QTTB) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Q32 Bio Inc in the past month.
Buy
1 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
42.250USD+341.95%
QTTB Analyst Recommendation Trends
In the current month, QTTB has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. QTTB average Analyst price target in the last month is 42.250.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
5
5
3
3
1
1
1
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
5
5
3
3
3
2
QTTB Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, QTTB EPS is projected to reach -0.332 in FY2026Q3, following reported EPS of -0.440 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.86
-0.68
-0.54
-0.33
-0.30
Actual
4.59
-0.54
-0.44
--
--
Surprise
+633.79%
+20.61%
+18.89%
--
--
FAQs
What is Q32 Bio Inc's price target?
Analysts forecast that Q32 Bio Inc's price target is USD 42.25, with the highest forecast at USD 59.00 and the lowest forecast at USD 34.00.
How have Q32 Bio IncQTTB's recent earnings per share performed?
The market expectation was USD -0.44, while Q32 Bio IncQTTB's earnings per share (EPS) for the previous quarter was USD -0.54. EPS for the next quarter is expected at USD -0.33.
What is the analyst rating for Q32 Bio Inc?
Based on the ratings of Q32 Bio Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.